Hidradenitis suppurativa successfully treated with adalimumab
DOI:
https://doi.org/10.15587/2313-8416.2015.51530Ключевые слова:
Hidradenitis suppurativa, biologics, apocrine glands, adalimumabАннотация
Aim: To discuss the new beneficial effect of adalimumab in the management of hidradenitis suppurativa(HS).
Case: We report a 25-year-old arabic female with a 14-year history with long-standing poorly controlled active hidradenitis suppurativa who was successfully treated with adalimumab.
Discussion: Hidradenitis suppurativa is a skin disorder characterized by the formation of multiple cysts, abscesses and sinus tracts in apocrine gland-bearing areas. The aetiology and pathogenesis of HS are unknown. Current medical and surgical therapies are only minimally effective at treating the disease. The biologic agent Adalimumab is a new promising agent for the treatment of HS.
Conclusion: The biologic agent adalimumab is an effective treatment for HS
Библиографические ссылки
Velpeau, A. A.; Bechet J. Z. (Ed.) (1839). Dictionnaire de médecine, un repertoire générale des Sciences Medicals sous le rapport theorique et pratique. Paris, 2, 1839–1891.
Brunsting, H. A. (1939). Hidradenitis suppurativa; abscess of apocrine sweat glands a study of the clinical and pathologic features with a report of twenty-two cases and a review of the literature. Archives of Dermatology and Syphilology, 39 (1), 108–120. doi: 10.1001/archderm.1939.014801901110100
Pillsbury, D. M., Shelley, W. B., Kligman, A. M.; Pillsbury, D. M. (Ed.) (1956). Bacterial infections of the skin. Dermatology. Philadelphia: Saunders WB, 482–484.
Plewig, G., Kligman, A. M. (1975). Acne: Morphogenesis and Treatment. Berlin: Springer-Verlag, 192–193. doi: 10.1007/978-3-642-96246-2
Naldi, L.; Jemec, G., Revuz, J., Leyden, J. (Eds.) (2006). Hidradenitis suppurativa. Springer Berlin Heidelberg, 58–64. doi: 10.1007/978-3-540-33101-8
Jemec, G. B. E., Heidenheim, M., Nielsen, N. H. (1996). The prevalence of hidradenitis suppurativa and its potential precursor lesions. Journal of the American Academy of Dermatology, 35 (2), 191–194. doi: 10.1016/s0190-9622(96)90321-7
Revuz, J. (2009). Hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology, 23 (9), 985–998. doi: 10.1111/j.1468-3083.2009.03356.x
Von der Werth, J., Wood, P., Irvine, A. D., McLean, W. H. I. (2006). Genetics of Hidradenitis Suppurativa. Hidradenitis Suppurativa, Berlin Heidelberg: Springer, 70–85. doi: 10.1007/978-3-540-33101-8_10
Alikhan, A., Lynch, P. J., Eisen, D. B. (2009). Hidradenitis suppurativa: A comprehensive review. Journal of the American Academy of Dermatology, 60 (4), 539–561. doi: 10.1016/j.jaad.2008.11.911
Mekkes, J. R., Bos, J. D. (2007). Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. British Journal of Dermatology, 158 (2), 370–374. doi: 10.1111/j.1365-2133.2007.08332.x
Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., Revuz, J. (2007). Quality of life impairment in hidradenitis suppurativa: A study of 61 cases. Journal of the American Academy of Dermatology, 56 (4), 621–623. doi: 10.1016/j.jaad.2006.08.061
Short, K. A., Kalu, G., Mortimer, P. S., Higgins, E. M. (2005). Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Clinical and Experimental Dermatology, 30 (5), 481–483. doi: 10.1111/j.1365-2230.2005.01875.x
Weber, L. A., Kantor, G. R., Bergfeld, W. F. (1990). Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma. Cutis, 45, 446–450.
Li, M., Hunt, M. J., Commens, C. A. (1997). Hidradenitis suppurativa, Dowling Degos disease and perianal squamous cell carcinoma. Australasian Journal of Dermatology, 38 (4), 209–211. doi: 10.1111/j.1440-0960.1997.tb01700.x
Talmant, J.-C., Bruant-Rodier, C., Nunziata, A. C., Rodier, J. F., Wilk, A. (2006). Dégénérescence de maladie de Verneuil en carcinome épidermoïde: à propos de 2 cas et revue de la littérature. Annales de Chirurgie Plastique Esthétique, 51 (1), 82–86. doi: 10.1016/j.anplas.2005.11.002
Maclean, G. M., Coleman, D. J. (2007). Three Fatal Cases of Squamous Cell Carcinoma Arising in Chronic Perineal Hidradenitis Suppurativa. The Annals of The Royal College of Surgeons of England, 89 (7), 709–712. doi: 10.1308/003588407x209392
Kurokawa, I., Nishimura, K., Yamanaka, K., Mizutani, H., Tsubura, A., Revuz, J. (2007). Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). Journal of Cutaneous Pathology, 34 (9), 675–678. doi: 10.1111/j.1600-0560.2006.00680.x
Barresi, V., Vitarelli, E., Barresi, G. (2008). Acne inversa complicated by squamous cell carcinoma in association with diffuse malignant peritoneal mesothelioma arising in the absence of predisposing factors: a case report. Journal of Cutaneous Pathology, 35 (1), 70–73. doi: 10.1111/j.1600-0560.2007.00766.x
Constantinou, C., Widom, K., Desantis, J., Obmann, M. (2008). Hidradenitis suppurativa complicated by squamous cell carcinoma. Am. Surg., 74, 1177–1181.
Katz, R. D., Goldberg, N. H. (2009). Marjolin Ulcer Arising Within Hidradenitis. Annals of Plastic Surgery, 62 (2), 173–174. doi: 10.1097/sap.0b013e31817d87b3
Giamarellos-Bourboulis, E. J., Antonopoulou, A., Petropoulou, C., Mouktaroudi, M., Spyridaki, E., Baziaka, F. et. al (2007). Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. British Journal of Dermatology, 156 (1), 51–56. doi: 10.1111/j.1365-2133.2006.07556.x
Jemec, G. B. E., Wendelboe, P. (1998). Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. Journal of the American Academy of Dermatology, 39 (6), 971–974. doi: 10.1016/s0190-9622(98)70272-5
Slade, D. E. M., Powell, B.W., Mortimer, P. S. (2003). Hidradenitis suppurativa: pathogenesis and management. British Journal of Plastic Surgery, 56 (5), 451–461. doi: 10.1016/s0007-1226(03)00177-2
Lebwohl, B., Sapadin, A. N. (2003). Infliximab for the treatment of hidradenitis suppurativa. Journal of the American Academy of Dermatology, 49 (5), 275–276. doi: 10.1016/s0190-9622(03)01132-0
Sullivan, T. P., Welsh, E., Kerdel, F. A., Burdick, A. E., Kirsner, R. S. (2003). Infliximab for hidradenitis suppurativa. British Journal of Dermatology, 149 (5), 1046–1049. doi: 10.1111/j.1365-2133.2003.05663.x
Adams, R., Gordon, K. B., Devenyi, A. G., Ioffreda, M. D. (2003). Severe hidradenitis suppurativa treated with infliximab infusion. Archives of Dermatology, 139 (12), 1540–1542. doi: 10.1001/archderm.139.12.1540
Mekkes, J. R., Hommes, D. W. (2004). Treatment of suppurative hidradenitis with surgical deroofing and infliximab. Ned. Tijdschr. Dermatol. Venereol., 14, 196–197.
Thielen, A.-M., Barde, C., Saurat, J.-H. (2006). Long-term infliximab for severe hidradenitis suppurativa. British Journal of Dermatology, 155 (5), 1105–1107. doi: 10.1111/j.1365-2133.2006.07528.x
Cusack, C., Buckley, C. (2006). Etanercept: effective in the management of hidradenitis suppurativa. British Journal of Dermatology, 154 (4), 726–729. doi: 10.1111/j.1365-2133.2005.07067.x
Campione, E., Mazzotta, A., Bianchi, L., Chimenti, S. (2006). Severe Acne Successfully Treated With Etanercept. Acta Dermato-Venereologica, 86 (3), 256–257. doi: 10.2340/00015555-004
Moul, D. K., Korman, N. J. (2006). Severe hidradenitis suppurativa treated with adalimumab. Archives of Dermatology, 142 (9), 1110–1112. doi: 10.1001/archderm.142.9.1110
Zouboulis, C. C.; Wolff, K., Goldsmith, L. A., Katz, S. I., Gilchrest, B. A., Paller, A. S., Leffell, D. J. (Eds.) (2009). Update on hidradenitis suppurativa/acne inversa. Fitzpatrick’s Dermatology in General Medicine. New York Chicago.
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2015 Iqbal A. Bukhari
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Наше издание использует положения об авторских правах Creative Commons CC BY для журналов открытого доступа.
Авторы, которые публикуются в этом журнале, соглашаются со следующими условиями:
1. Авторы оставляют за собой право на авторство своей работы и передают журналу право первой публикации этой работы на условиях лицензии Creative Commons CC BY, которая позволяет другим лицам свободно распространять опубликованную работу с обязательной ссылкой на авторов оригинальной работы и первую публикацию работы в этом журнале.
2. Авторы имеют право заключать самостоятельные дополнительные соглашения, которые касаются неэксклюзивного распространения работы в том виде, в котором она была опубликована этим журналом (например, размещать работу в электронном хранилище учреждения или публиковать в составе монографии), при условии сохранения ссылки на первую публикацию работы в этом журнале .
